Upcoming Health Adviser Review: Potential New Cure for Sickle Cell Disease on the Horizon


The FDA is reviewing a potential new therapy for sickle cell disease that targets its genetic root. This CRISPR-based gene therapy, which is the first of its type in the United States, has the potential to transform treatment for the largely Black sickle cell patient population. Approval is expected in December, with healthcare experts holding high hopes.

Abstract Written By:
Denson Natividad
October 27, 2023

Get updates from Caring Support

We'll keep you updated on all new application updates and features!

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.